Literature DB >> 18264683

Oxidative stress parameters in patients with slow coronary flow.

Yasar Enli1, Mehmet Turk, Ramazan Akbay, Harun Evrengul, Halil Tanriverdi, Omur Kuru, Deniz Seleci, Asuman Kaftan, Oztekin Ozer, Havane Enli.   

Abstract

INTRODUCTION: We investigated the probable role of free-radical damage in the pathogenesis of slow coronary flow (SCF) by using oxidative stress parameters.
METHODS: Sixty-four patients with angiographically proven SCF and 63 patients with normal coronary flow (NCF) pattern with similar risk profiles were enrolled in this study. We measured erythrocyte superoxide dismutase (SOD), reduced glutathione (GSH), serum malondialdehyde (MDA), catalase and myeloperoxidase (MPO) levels in all subjects.
RESULTS: There were statistically significant differences in the levels of erythrocyte SOD, GSH and serum MDA between the 2 groups. Serum MDA (P = 0.003) and erythrocyte SOD levels (P = 0.0001) were increased in the SCF group. The level of erythrocyte GSH (P = 0.010) was lower in patients with SCF. There were no differences between the groups' serum catalase (P = 0.682) and MPO levels (P = 0.070).
CONCLUSION: Our data showed that in patients with SCF, serum MDA and erythrocyte SOD levels were increased while erythrocyte GSH levels were decreased significantly, compared with NCF patients. These results indicate that free-radical damage may play a role in the pathogenesis of SCF.

Entities:  

Mesh:

Year:  2008        PMID: 18264683     DOI: 10.1007/s12325-008-0011-4

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  10 in total

1.  Relationship between serum visfatin levels and coronary slow-flow phenomenon.

Authors:  Huseyin Altug Cakmak; Serkan Aslan; Ahmet Arif Yalcin; Ibrahim Faruk Akturk; Burce Yalcin; Fatih Uzun; Derya Ozturk; Mehmet Erturk; Mehmet Gul
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

2.  Clinical analysis of the risk factors of slow coronary flow.

Authors:  Shuang Xia; Song-Bai Deng; Yang Wang; Jun Xiao; Jian-Lin Du; Yu Zhang; Xi-Chun Wang; Ye-Qing Li; Rui Zhao; Li He; Yu-Luan Xiang; Qiang She
Journal:  Heart Vessels       Date:  2011-01-05       Impact factor: 2.037

3.  Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity.

Authors:  E Melles; H Jörnvall; S Tryggvason; K Gemzell Danielsson; K Ekberg; K Tryggvason; J Wahren; T Bergman
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

4.  Increased serum resistin levels in patients with coronary slow-flow phenomenon.

Authors:  A Canga; M Cetin; S A Kocaman; M E Durakoğlugil; A Kırbaş; T Erdoğan; A Temiz; A Yılmaz; Y Ciçek
Journal:  Herz       Date:  2013-02-13       Impact factor: 1.443

5.  Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon.

Authors:  Ilker Murat Caglar; Cem Ozde; Ismail Biyik; Fatma Nihan Turhan Caglar; Ibrahim Faruk Akturk; Murat Ugurlucan; Osman Karakaya
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

Review 6.  The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow.

Authors:  Ömer Şatıroğlu; Murtaza Emre Durakoğlugil; Mustafa Çetin; Yüksel Çiçek; Turan Erdoğan; Hakan Duman
Journal:  Interv Med Appl Sci       Date:  2016-12

7.  Oxidant-Antioxidant balance in patients with coronary slow flow.

Authors:  Sadettin Selcuk Baysal; Sahbender Koc
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

8.  Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon.

Authors:  Xin-Tong Dai; Tian-Zhong Kong; Xiao-Jiao Zhang; Bo Luan; Yong Wang; Ai-Jie Hou
Journal:  BMC Cardiovasc Disord       Date:  2022-08-08       Impact factor: 2.174

9.  Plasma lipoprotein(a) levels in patients with slow coronary flow.

Authors:  Habil Yucel; Abdullah Dogan; Ahmet Altinbas; Salaheddin Akcay; Atilla Icli; Betul Mermi Ceyhan
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-11-18       Impact factor: 1.426

10.  Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon.

Authors:  Erkan Demirci; Oğuzhan Çelik; Macit Kalçık; Lütfü Bekar; Mucahit Yetim; Tolga Doğan
Journal:  Interv Med Appl Sci       Date:  2019-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.